Viewing Study NCT02712437



Ignite Creation Date: 2024-05-06 @ 8:19 AM
Last Modification Date: 2024-10-26 @ 11:58 AM
Study NCT ID: NCT02712437
Status: TERMINATED
Last Update Posted: 2017-09-08
First Post: 2016-03-15

Brief Title: Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer
Sponsor: University of Michigan Rogel Cancer Center
Organization: University of Michigan Rogel Cancer Center

Study Overview

Official Title: Prospective Study Evaluating the Use of PROSPECT a Cognitive Behavioral Therapy-based Internet Module to Reduce Insomnia in Patients With Early Stage Breast Cancer
Status: TERMINATED
Status Verified Date: 2017-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: The study was terminated because of low accrual
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Women with early stage breast cancer may experience difficulty falling asleep or staying asleep If this occurs for more than 4 weeks these participants may have chronic insomnia Chronic insomnia can lead to difficulty coping with stress changes in mood increased use of medications for sleep and an overall decrease in quality of life

The investigators have developed an internet-based website that is designed to help people manage symptoms typically experienced by breast cancer survivors including insomnia fatigue pain and overall poor quality of life The investigators want to learn whether this type of treatment can reduce chronic insomnia and improve the way subjects feel using both questionnaires and a special form of a wrist watch This information may help the investigators better manage sleep difficulties in subjects who experience these symptoms after diagnosis of their breast cancer
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None